✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Sarcosine is an investigational drug.
There have been 15 clinical trials for Sarcosine. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2012.
The most common disease conditions in clinical trials are Schizophrenia, Psychotic Disorders, and Mental Disorders. The leading clinical trial sponsors are China Medical University Hospital, National Science Council, Taiwan, and University of Aarhus.
There are three hundred and eighty-five US patents protecting this investigational drug and thirty-one international patents.
Recent Clinical Trials for Sarcosine
|Evaluation of Efficacy and Safety of add-on Sarcosine in Patients With Major Depressive Disorder||All India Institute of Medical Sciences, Bhubaneswar||Phase 4|
|Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT||University of Aarhus||Early Phase 1|
|Carbon-11 Labeled Sarcosine in Prostate Cancer||National Cancer Institute (NCI)|
Top disease conditions for Sarcosine
Top clinical trial sponsors for Sarcosine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Sarcosine||See Plans and Pricing||Bombesin antagonists with deletion of net-residue at the C-terminus||Imperial Chemical Industries PLC (London, GB2)||See Plans and Pricing|
|Sarcosine||See Plans and Pricing||Anticalculus oral composition||Colgate-Palmolive Company (Piscataway, NJ)||See Plans and Pricing|
|Sarcosine||See Plans and Pricing||Halogenated aminohexanoates and aminobutyrates antimicrobial agents||The Procter & Gamble Company (Cincinnati, OH)||See Plans and Pricing|
|Sarcosine||See Plans and Pricing||Endothelin antagonistic cyclic pentapeptides||Banyu Pharmaceutical Co., Ltd. (Tokyo, JP)||See Plans and Pricing|
|Sarcosine||See Plans and Pricing||Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated immune response||The United States of America as represented by the Secretary of (Washington, DC)||See Plans and Pricing|
|Sarcosine||See Plans and Pricing||Angiotensin II receptor blocking imidazoles||E. I. Du Pont de Nemours and Company (Wilmington, DE)||See Plans and Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Sarcosine||Australia||AU1736688||2007-06-05||See Plans and Pricing|
|Sarcosine||Belgium||BE1002286||2007-06-05||See Plans and Pricing|
|Sarcosine||Brazil||BR8802720||2007-06-05||See Plans and Pricing|
|Sarcosine||Switzerland||CH676239||2007-06-05||See Plans and Pricing|
|Sarcosine||China||CN88103413||2007-06-05||See Plans and Pricing|
|Sarcosine||Germany||DE3818958||2007-06-05||See Plans and Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|